Antimitochondrial Antibody-Positive Myositis - 29/01/24
Doi : 10.1016/j.amjmed.2023.10.009
Kosuke Ishizuka, MD, PhD a, ⁎ 
, Yoshiyuki Ohira, MD, PhD b
, Yoshiyuki Ohira, MD, PhD b a Department of General Medicine, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan
b Division of General Internal Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
⁎Requests for reprints should be addressed to Kosuke Ishizuka, MD, PhD, Department of General Medicine, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama-city, Kanagawa pref, Japan.Department of General MedicineYokohama City University School of Medicine3-9 Fukuura, Kanazawa-ku, Yokohama-cityKanagawa prefJapan
| Funding: None. |
|
| Conflicts of Interest: None. |
|
| Authorship: All authors had access to the data and a role in writing the manuscript. |
© 2023
Elsevier Inc. Reservados todos los derechos.
Vol 137 - N° 2
P. e38-e39 - février 2024 Regresar al número
Artículo precedente
- Shark Fin Sign
- Ryohei Ono, Togo Iwahana, Hirotoshi Kato, Kaoruko Aoki, Yoshio Kobayashi
- Clinical Efficacy of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis in Immunocompromised Patients Treated During Omicron Sublineages Diffusion. Real-Life Experience from ASST Lecco
- Federico Conti, Silvia Pontiggia, Valentina Morena, Francesca Alberton, Flavia Badalucco, Chiara Molteni, Lucia Bradanini, Alessandro Pandolfo, Laura Galli, Antonella Castagna, Stefania Piconi
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?